GSK Clinical Trials [clinicaltrials_resource:1a067787f6a83205508c1b902c0ca32b]
Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) [clinicaltrials:NCT00244686]clinicaltrials:NCT01014988Promacta Pregnancy Registry [clinicaltrials:NCT01064336]clinicaltrials:NCT01077518clinicaltrials:NCT01137981Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors [clinicaltrials:NCT01138033]Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO) [clinicaltrials:NCT01160094]clinicaltrials:NCT01160211Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects [clinicaltrials:NCT01190176]Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study [clinicaltrials:NCT01190189]clinicaltrials:NCT01200589ZIAGEN® Post-marketing Surveillance [clinicaltrials:NCT01205243]The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study [clinicaltrials:NCT01249365]GSK1120212 Rollover Study [clinicaltrials:NCT01376310]A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency [clinicaltrials:NCT01458067]clinicaltrials:NCT01532310Dolutegravir Expanded Access Study [clinicaltrials:NCT01536873]clinicaltrials:NCT01563068Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007 [clinicaltrials:NCT01563146]Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011 [clinicaltrials:NCT01563159]clinicaltrials:NCT01582932A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers [clinicaltrials:NCT01587703]BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 [clinicaltrials:NCT01597622]An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures [clinicaltrials:NCT01607346]Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A [clinicaltrials:NCT01610414]clinicaltrials:NCT01632241clinicaltrials:NCT01639339clinicaltrials:NCT01649765Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma [clinicaltrials:NCT01649778]clinicaltrials:NCT01663623A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects [clinicaltrials:NCT01677741]clinicaltrials:NCT01705977An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma [clinicaltrials:NCT01706198]Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI) [clinicaltrials:NCT01716533]A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [clinicaltrials:NCT01725139]clinicaltrials:NCT01729455Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis [clinicaltrials:NCT01733862]clinicaltrials:NCT01746108clinicaltrials:NCT01750918An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil [clinicaltrials:NCT01751139]
overall contact [clinicaltrials_vocabulary:overall-contact]
GSK Clinical Trials [clinicaltrials_resource:1a067787f6a83205508c1b902c0ca32b]
Bio2RDF identifier
1a067787f6a83205508c1b902c0ca32b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1a067787f6a83205508c1b902c0ca32b
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
GSKClinicalSupportHD@gsk.com
last name [clinicaltrials_vocabulary:last-name]
GSK Clinical Trials
phone [clinicaltrials_vocabulary:phone]
877-379-3718
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:1a067787f6a83205508c1b902c0ca32b
title
GSK Clinical Trials
@en
type
label
GSK Clinical Trials [clinicaltrials_resource:1a067787f6a83205508c1b902c0ca32b]
@en